Therapies using cannabinoid receptor ligands will have efficiency in reducing tumor burden in malignant lymphoma

Clinical Trials, Studies and Publications:

Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation

Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma

Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma